1. Asymptomatic incidence and duration of prostate cancer;Etzioni;Am J Epidemiol,1998
2. Surveillance, Epidemiology, and End Results (SEER) Program SEER*Stat Database: Incidence - SEER 9 Regs Limited-Use, Nov 2006 Sub (1973-2005), National Cancer Institute, DCCPS, Surveillance Research Program, Cancer Statistics Branch, released April 2008, based on the November 2007 submission; [cited]. Available at www.seer.cancer.gov. Accessed August 9, 2011.
3. Screening for prostate cancer: estimating the magnitude of overdetection;McGregor;CMAJ,1998
4. Lead times and overdetection due to prostate-specific antigen screening: estimates from the European Randomized Study of Screening for Prostate Cancer;Draisma;J Natl Cancer Inst,2003
5. Overdiagnosis due to prostate-specific antigen screening: lessons from U.S. prostate cancer incidence trends;Etzioni;J Natl Cancer Inst,2002